中国综合临床
中國綜閤臨床
중국종합림상
CLINICAL MEDICINE OF CHINA
2013年
4期
384-386
,共3页
潘丽萍%宋宏%刘珏%顾凌燕%章蓓蕾
潘麗萍%宋宏%劉玨%顧凌燕%章蓓蕾
반려평%송굉%류각%고릉연%장배뢰
医院感染%革兰阳性球菌%耐药性%药敏试验
醫院感染%革蘭暘性毬菌%耐藥性%藥敏試驗
의원감염%혁란양성구균%내약성%약민시험
Nosocomial infection%Gram-positive cocci%Distribution%Drug resistance
目的 探讨医院感染革兰阳性球菌的分布和耐药性,为抗感染药物的合理使用提供依据.方法 收集2009年1月至2011年12月我院分离的革兰阳性球菌125株,采用K-B法进行药敏试验,按CLSI 2009年版标准判断结果.结果 检出的革兰阳性球菌依次为金黄色葡萄球菌68株(54.4%)、屎肠球菌22株(17.6%)、凝固酶阴性葡萄球菌20株(16.0%)、粪肠球菌6株(4.8%)、溶血葡萄球菌7株(5.6%),其他阳性球菌2株(1.6%).检出耐甲氧西林金黄色葡萄球菌(MRSA)40株(占金黄色葡萄球菌的58.8%),甲氧西林敏感金黄色葡萄球菌(MSSA) 28株(占金黄色葡萄球菌的41.1%).药敏试验显示,MRSA对庆大霉素、克林霉素、红霉素和环丙沙星的耐药率高达87.5%~95.0%,凝固酶阴性葡萄球菌对青霉素、红霉素、克林霉素和庆大霉素的耐药率达65.0%~95.0%,屎肠球菌和粪肠球菌对红霉素、高浓度庆大霉素和环丙沙星的耐药率为86.4%~ 100%和50.0%~ 66.7%.未检测到万古霉素、替考拉宁和利奈唑胺的耐药菌.结论 金黄色葡萄球菌为医院感染革兰阳性球菌的主要菌群,革兰阳性球菌的耐药现象非常严重.临床医师应高度重视革兰阳性球菌的高耐药情况.
目的 探討醫院感染革蘭暘性毬菌的分佈和耐藥性,為抗感染藥物的閤理使用提供依據.方法 收集2009年1月至2011年12月我院分離的革蘭暘性毬菌125株,採用K-B法進行藥敏試驗,按CLSI 2009年版標準判斷結果.結果 檢齣的革蘭暘性毬菌依次為金黃色葡萄毬菌68株(54.4%)、屎腸毬菌22株(17.6%)、凝固酶陰性葡萄毬菌20株(16.0%)、糞腸毬菌6株(4.8%)、溶血葡萄毬菌7株(5.6%),其他暘性毬菌2株(1.6%).檢齣耐甲氧西林金黃色葡萄毬菌(MRSA)40株(佔金黃色葡萄毬菌的58.8%),甲氧西林敏感金黃色葡萄毬菌(MSSA) 28株(佔金黃色葡萄毬菌的41.1%).藥敏試驗顯示,MRSA對慶大黴素、剋林黴素、紅黴素和環丙沙星的耐藥率高達87.5%~95.0%,凝固酶陰性葡萄毬菌對青黴素、紅黴素、剋林黴素和慶大黴素的耐藥率達65.0%~95.0%,屎腸毬菌和糞腸毬菌對紅黴素、高濃度慶大黴素和環丙沙星的耐藥率為86.4%~ 100%和50.0%~ 66.7%.未檢測到萬古黴素、替攷拉寧和利奈唑胺的耐藥菌.結論 金黃色葡萄毬菌為醫院感染革蘭暘性毬菌的主要菌群,革蘭暘性毬菌的耐藥現象非常嚴重.臨床醫師應高度重視革蘭暘性毬菌的高耐藥情況.
목적 탐토의원감염혁란양성구균적분포화내약성,위항감염약물적합리사용제공의거.방법 수집2009년1월지2011년12월아원분리적혁란양성구균125주,채용K-B법진행약민시험,안CLSI 2009년판표준판단결과.결과 검출적혁란양성구균의차위금황색포도구균68주(54.4%)、시장구균22주(17.6%)、응고매음성포도구균20주(16.0%)、분장구균6주(4.8%)、용혈포도구균7주(5.6%),기타양성구균2주(1.6%).검출내갑양서림금황색포도구균(MRSA)40주(점금황색포도구균적58.8%),갑양서림민감금황색포도구균(MSSA) 28주(점금황색포도구균적41.1%).약민시험현시,MRSA대경대매소、극림매소、홍매소화배병사성적내약솔고체87.5%~95.0%,응고매음성포도구균대청매소、홍매소、극림매소화경대매소적내약솔체65.0%~95.0%,시장구균화분장구균대홍매소、고농도경대매소화배병사성적내약솔위86.4%~ 100%화50.0%~ 66.7%.미검측도만고매소、체고랍저화리내서알적내약균.결론 금황색포도구균위의원감염혁란양성구균적주요균군,혁란양성구균적내약현상비상엄중.림상의사응고도중시혁란양성구균적고내약정황.
Objective To discuss the distributions and drug resistance of gram-positive cocci and provide scientific basis for reasonable use of antimicrobial drugs.Methods One hundred and twenty-five strains were isolated and cultured in our department from January 2009 to December 2011.The drug susceptibility was tested by K-B method and the results were judged by the criteria guideline of CLSI 2009.Results The main strains of separated cocci were Staphylococcus aureus (68,54.4%),Enterococcus faecium (22,17.6%),coagulase-negative staphylococcus (CNS) (20,16.0%),Enterococcus faecalis (6,4.8%),Staphylococcus haemolyticus(7,5.6%)and other gram-positive cocci (2,1.6%).Methicillin-resistant S.aureus (MRSA) and Methicillin-susceptible S.aureus (MSSA) detected were 40 and 28 strains(accounted for 58.8% and 41.1% of S.aureaus).The results of drug susceptibility tests showed that the drug resistant rate of MRSA to Gentamicin,Clidamycin,Erythromycin and Ciprofloxacin was up to 87.5%-95.0%,and the drug resistant rate of coagulasenegative staphylococcus to Penicillin,Erythromycin,Clidamycin and Gentamicin was up to 65.0%-95.0%,besides,the drug resistant rate of E.faecalis and E.faecium to Erythromycin,high level Gentamicin and Ciprofloxacin were 86.4%-100% and 50.0%-66.7%,respectively.No strains with drug resistant to Vancomycin,Teicoplanin and Linezolid were detected.Conclusion S.aureus was the main strains of nosocomial infection of gram cocci.The resistance of gram-positive cocci is severe,so clinicians should attaches great importance to high drug resistance of gram-positive cocci.